Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
14.7M
-
Shares change
-
+11.2K
-
Total reported value, excl. options
-
$275M
-
Value change
-
-$5.49M
-
Put/Call ratio
-
0.41
-
Number of buys
-
42
-
Number of sells
-
-31
-
Price
-
$18.81
Significant Holders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) as of Q3 2024
95 filings reported holding JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share as of Q3 2024.
Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.7M shares
of 27.8M outstanding shares and own 52.8% of the company stock.
Largest 10 shareholders include Velan Capital Investment Management LP (1.43M shares), Soleus Capital Management, L.P. (1.34M shares), Carlyle Group Inc. (1.07M shares), Qiming U.S. Ventures Management, LLC (929K shares), BlackRock, Inc. (800K shares), VANGUARD GROUP INC (694K shares), Samsara BioCapital, LLC (585K shares), Polar Capital Holdings Plc (582K shares), FRANKLIN RESOURCES INC (580K shares), and MORGAN STANLEY (566K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.